Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

We read this article with interest.1 The potential long-term neurologic sequalae and, in particular, cognitive impairment following CAR T-cell therapy are receiving greater attention given the treatment's increasing availability and use.